Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the ...
H.C. Wainwright lowered the firm’s price target on Canoo (GOEV) to $2 from $4 and keeps a Buy rating on the shares post the Q3 report.
In a report released today, Kevin Dede from H.C. Wainwright reiterated a Hold rating on Ryvyl (RVYL – Research Report). The ...
On Thursday, Joby Aviation Inc (JOBY) stock saw a modest uptick, ending the day at $5.91 which represents a slight increase of $0.01 or 0.17% from the prior close of $5.9. The stock opened at $5.95 ...
Q3 2024 Earnings Call Transcript November 14, 2024 Emily Bodnar – H.C. Wainwright: Operator: Thank you for standing by. I ...
On Thursday, SpringWorks Therapeutics Inc (SWTX) stock saw a modest uptick, ending the day at $36.55 which represents a slight increase of $1.84 or 5.30% from the prior close of $34.71. The stock ...
scPharmaceuticals Inc. (NASDAQ: SCPH) Q3 2024 Earnings Call Transcript November 13, 2024 ...
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Hosted on MSN2d
Syros cut to neutral by H.C. Wainwright on failed drug studyH.C. Wainwright has downgraded Syros Pharmaceuticals (NASDAQ:SYRS) to neutral from buy, citing Tuesday’s announcement that a ...
MARA shares down as Q3 earnings miss estimates with lower revenue and adjusted loss, analysts maintain mixed views and price ...
We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at ...
Phunware (NASDAQ:PHUN) shares retreated 11% in Tuesday late morning trading after H.C. Wainwright & Co. downgraded the application software company to Neutral from Buy, as analyst Scott Buck became ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback